The total return over the past 12 months is -3.90% vs. +19.37% for the S&P 500. So far it's up +3.63% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (3.90%) | (6.35%) | (21.75%) | N/A | N/A | N/A |
| Total Return CAGR | (3.90%) | (6.35%) | (21.54%) | N/A | N/A | N/A |
| Revenue CAGR | (0.83%) | (31.26%) | +40.61% | N/A | N/A | N/A |
| Net Income CAGR | N/A | (55.27%) | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | (59.01%) | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | (55.07%) | +233.78% | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
BioNTech SE (BNTX)
| Year | Start price | End price | BNTX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $95.20 | $98.66 | +3.63% | +12.92% | (9.29%) |
| 2025 | $113.95 | $95.20 | (16.45%) | +17.72% | (34.17%) |
| 2024 | $105.54 | $113.95 | +7.97% | +24.89% | (16.92%) |
| 2023 | $150.22 | $105.54 | (29.74%) | +26.19% | (55.93%) |
| 2022 | $257.80 | $150.22 | (40.95%) | (18.17%) | (22.78%) |
| 2021 | $81.52 | $257.80 | +216.24% | +28.74% | +187.50% |
| 2020 | $33.88 | $81.52 | +140.61% | +18.37% | +122.24% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
